These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 9126664

  • 21. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
    Strandberg TE, Feely J, Sigurdsson EL, DISCOVERY study group.
    Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
    [Abstract] [Full Text] [Related]

  • 22. Atorvastatin in the treatment of primary hypercholesterolemia and mixed dyslipidemias.
    Yee HS, Fong NT.
    Ann Pharmacother; 1998 Oct; 32(10):1030-43. PubMed ID: 9793596
    [Abstract] [Full Text] [Related]

  • 23. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
    Plans-Rubió P.
    Am J Cardiovasc Drugs; 2006 Oct; 6(3):177-88. PubMed ID: 16780391
    [Abstract] [Full Text] [Related]

  • 24. Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.
    Lewis JH, Mortensen ME, Zweig S, Fusco MJ, Medoff JR, Belder R, Pravastatin in Chronic Liver Disease Study Investigators.
    Hepatology; 2007 Nov; 46(5):1453-63. PubMed ID: 17668878
    [Abstract] [Full Text] [Related]

  • 25. A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia.
    Saito Y, Yamada N, Teramoto T, Itakura H, Hata Y, Nakaya N, Mabuchi H, Tushima M, Sasaki J, Ogawa N, Goto Y.
    Atherosclerosis; 2002 Jun; 162(2):373-9. PubMed ID: 11996957
    [Abstract] [Full Text] [Related]

  • 26. Efficacy of rosuvastatin compared with other statins at selected starting doses in hypercholesterolemic patients and in special population groups.
    Blasetto JW, Stein EA, Brown WV, Chitra R, Raza A.
    Am J Cardiol; 2003 Mar 06; 91(5A):3C-10C; discussion 10C. PubMed ID: 12646336
    [Abstract] [Full Text] [Related]

  • 27. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia.
    Lee SH, Chung N, Kwan J, Kim DI, Kim WH, Kim CJ, Kim HS, Park SH, Seo HS, Shin DG, Shin YW, Shim WJ, Ahn TH, Ho Yun K, Yoon MH, Cha KS, Choi SW, Han SW, Hyon MS.
    Clin Ther; 2007 Nov 06; 29(11):2365-73. PubMed ID: 18158077
    [Abstract] [Full Text] [Related]

  • 28. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
    Illingworth DR, Crouse JR, Hunninghake DB, Davidson MH, Escobar ID, Stalenhoef AF, Paragh G, Ma PT, Liu M, Melino MR, O'Grady L, Mercuri M, Mitchel YB, Simvastatin Atorvastatin HDL Study Group.
    Curr Med Res Opin; 2001 Nov 06; 17(1):43-50. PubMed ID: 11464446
    [Abstract] [Full Text] [Related]

  • 29. Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial.
    Schwartz GG, Bolognese MA, Tremblay BP, Caplan R, Hutchinson H, Raza A, Cressman M.
    Am Heart J; 2004 Jul 06; 148(1):e4. PubMed ID: 15215813
    [Abstract] [Full Text] [Related]

  • 30. Beneficial effects of atorvastatin on sd LDL and LDL phenotype B in statin-naive patients and patients previously treated with simvastatin or pravastatin.
    Baldassarre S, Scruel O, Deckelbaum RJ, Dupont IE, Ducobu J, Carpentier YA.
    Int J Cardiol; 2005 Oct 10; 104(3):338-45. PubMed ID: 16186066
    [Abstract] [Full Text] [Related]

  • 31. Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. I. A dose-response study.
    Hunninghake DB, Knopp RH, Schonfeld G, Goldberg AC, Brown WV, Schaefer EJ, Margolis S, Dobs AS, Mellies MJ, Insull W.
    Atherosclerosis; 1990 Nov 10; 85(1):81-9. PubMed ID: 2126437
    [Abstract] [Full Text] [Related]

  • 32. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.
    Nissen SE, Tuzcu EM, Schoenhagen P, Brown BG, Ganz P, Vogel RA, Crowe T, Howard G, Cooper CJ, Brodie B, Grines CL, DeMaria AN, REVERSAL Investigators.
    JAMA; 2004 Mar 03; 291(9):1071-80. PubMed ID: 14996776
    [Abstract] [Full Text] [Related]

  • 33. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.
    Clin Ther; 2008 Jun 03; 30(6):1089-101. PubMed ID: 18640465
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and safety of pravastatin in patients with primary hypercholesterolemia. II. Once-daily versus twice-daily dosing.
    Hunninghake DB, Mellies MJ, Goldberg AC, Kuo PT, Kostis JB, Schrott HG, Insull W, Pan HY.
    Atherosclerosis; 1990 Dec 03; 85(2-3):219-27. PubMed ID: 2129319
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and safety of ezetimibe added on to atorvastatin (20 mg) versus uptitration of atorvastatin (to 40 mg) in hypercholesterolemic patients at moderately high risk for coronary heart disease.
    Conard SE, Bays HE, Leiter LA, Bird SR, Rubino J, Lowe RS, Tomassini JE, Tershakovec AM.
    Am J Cardiol; 2008 Dec 01; 102(11):1489-94. PubMed ID: 19026302
    [Abstract] [Full Text] [Related]

  • 36. [Clinical study of the month. REVERAL and PROVE-IT: confirmation of the concept " the lower, the better" for cholesterol therapy in patients with coronary heart disease].
    Scheen AJ, Kulbertus H.
    Rev Med Liege; 2004 Mar 01; 59(3):167-73. PubMed ID: 15139406
    [Abstract] [Full Text] [Related]

  • 37. Effect of statins on LDL particle size in patients with familial combined hyperlipidemia: a comparison between atorvastatin and pravastatin.
    Sirtori CR, Calabresi L, Pisciotta L, Cattin L, Pauciullo P, Montagnani M, Manzato E, Bittolo Bon G, Fellin R.
    Nutr Metab Cardiovasc Dis; 2005 Feb 01; 15(1):47-55. PubMed ID: 15871851
    [Abstract] [Full Text] [Related]

  • 38. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).
    Jones P, Kafonek S, Laurora I, Hunninghake D.
    Am J Cardiol; 1998 Mar 01; 81(5):582-7. PubMed ID: 9514454
    [Abstract] [Full Text] [Related]

  • 39. Pitavastatin and Atorvastatin double-blind randomized comPArative study among hiGh-risk patients, including thOse with Type 2 diabetes mellitus, in Taiwan (PAPAGO-T Study).
    Liu PY, Lin LY, Lin HJ, Hsia CH, Hung YR, Yeh HI, Wu TC, Chen JY, Chien KL, Chen JW.
    PLoS One; 2013 Mar 01; 8(10):e76298. PubMed ID: 24098467
    [Abstract] [Full Text] [Related]

  • 40. Atorvastatin: an updated review of its pharmacological properties and use in dyslipidaemia.
    Malhotra HS, Goa KL.
    Drugs; 2001 Mar 01; 61(12):1835-81. PubMed ID: 11693468
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.